GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Addex Therapeutics Ltd (CHIX:ADXNz) » Definitions » Institutional Ownership

Addex Therapeutics (CHIX:ADXNZ) Institutional Ownership : 1.96% (As of Dec. 15, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Addex Therapeutics Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Addex Therapeutics's institutional ownership is 1.96%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Addex Therapeutics's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Addex Therapeutics's Float Percentage Of Total Shares Outstanding is 78.33%.


Addex Therapeutics Institutional Ownership Historical Data

The historical data trend for Addex Therapeutics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Addex Therapeutics Institutional Ownership Chart

Addex Therapeutics Historical Data

The historical data trend for Addex Therapeutics can be seen below:

2024-02-29 2024-03-31 2024-04-30 2024-05-31 2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30
Institutional Ownership 1.39 1.40 1.59 1.60 1.60 1.59 1.59 1.93 1.95 1.96

Addex Therapeutics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Addex Therapeutics Business Description

Traded in Other Exchanges
Address
Chemin des Mines 9, Geneva, CHE, 1202
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.

Addex Therapeutics Headlines

No Headlines